About the journal
Nature reviews. Cancer is a journal published by Nature Portfolio in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Nature Portfolio
- ISSN
- 1474-1768 · 1474-175X
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- http://www.nature.com/nrc/index.html
Index listings
- MEDLINE · 2001-01-01
- PUBMED · 2011-01-20
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
4697
Last recorded publication year
2026
h-index
597
i10-index
1760
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 73%
- ORCID iDs in current deposits
- 35%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Cancer
- Source type
- journal
- NLM unique ID (PubMed)
- 101124168
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
Show all subjects (50)
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- RNA modifications and cancer
- DNA Repair Mechanisms
- Cancer Immunotherapy and Biomarkers
- DNA Repair Mechanisms
- Cancer Immunotherapy and Biomarkers
- Cancer Research and Treatments
- Cancer Research and Treatments
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Microtubule and mitosis dynamics
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Microtubule and mitosis dynamics
- Genomics and Chromatin Dynamics
- Genomics and Chromatin Dynamics
- Immune cells in cancer
- Immune cells in cancer
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Genetic factors in colorectal cancer
- Angiogenesis and VEGF in Cancer
- Genetic factors in colorectal cancer
- Angiogenesis and VEGF in Cancer
- BRCA gene mutations in cancer
- BRCA gene mutations in cancer
- RNA Research and Splicing
- RNA Research and Splicing
- Cancer-related gene regulation
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Histone Deacetylase Inhibitors Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ